SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-14-004859
Filing Date
2014-09-02
Accepted
2014-09-02 06:29:39
Documents
6
Period of Report
2014-08-28
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctix_8k.htm 8-K 32470
2 CELLCEUTIX ARUDA AGREEMENT ctix_ex1046.htm EX-10.46 95583
3 AMENDMENT TO MENON-CELLCEUTIX AGREEMENT ctix_ex1047.htm EX-10.47 48347
4 ASSIGNMENT OF PATENT RIGHTS TO CELLCEUTIX ctix_ex1048.htm EX-10.48 13713
5 PRESS RELEASE ctix_ex991.htm EX-99.1 15206
6 img001.jpg GRAPHIC 132490
  Complete submission text file 0001477932-14-004859.txt   389333
Mailing Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915
Business Address 100 CUMMING CENTER SUITE 151-B BEVERLY MA 01915 (978)-633-3623
Cellceutix CORP (Filer) CIK: 0001355250 (see all company filings)

IRS No.: 134303398 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-52321 | Film No.: 141076383
SIC: 2834 Pharmaceutical Preparations